|
Volumn 105, Issue 5, 2010, Pages 327-333
|
Cost of Illness in Alzheimer's disease;Krankheitskosten bei Alzheimer-Demenz
|
Author keywords
Alzheimer's disease; Cost; Dementia; Level of care; Memantine
|
Indexed keywords
HYPNOTIC AGENT;
MEMANTINE;
NOOTROPIC AGENT;
PSYCHOTROPIC AGENT;
SEDATIVE AGENT;
HYPNOTIC SEDATIVE AGENT;
ALZHEIMER DISEASE;
ARTICLE;
CONTROLLED STUDY;
COST OF ILLNESS;
DRUG COST;
FEMALE;
GERMANY;
HEALTH CARE COST;
HEALTH CARE DELIVERY;
HEALTH CARE DISTRIBUTION;
HEALTH INSURANCE;
HOSPITALIZATION;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL RECORD;
NURSING CARE;
PATIENT CARE;
POPULATION RESEARCH;
AGED;
COMPARATIVE STUDY;
COST BENEFIT ANALYSIS;
DISABILITY;
ECONOMICS;
GERIATRIC NURSING;
MORTALITY;
PUBLIC HEALTH;
RETROSPECTIVE STUDY;
STATISTICS AND NUMERICAL DATA;
SURVIVAL RATE;
VERY ELDERLY;
AGED;
AGED, 80 AND OVER;
ALZHEIMER DISEASE;
COST-BENEFIT ANALYSIS;
DISABILITY EVALUATION;
DRUG COSTS;
FEMALE;
GERIATRIC NURSING;
GERMANY;
HEALTH CARE COSTS;
HOSPITALIZATION;
HUMANS;
HYPNOTICS AND SEDATIVES;
MALE;
MEMANTINE;
NATIONAL HEALTH PROGRAMS;
NOOTROPIC AGENTS;
PSYCHOTROPIC DRUGS;
RETROSPECTIVE STUDIES;
SURVIVAL RATE;
|
EID: 77954626809
PISSN: 07235003
EISSN: None
Source Type: Journal
DOI: 10.1007/s00063-010-1060-4 Document Type: Article |
Times cited : (9)
|
References (10)
|